Depot Buprenorphine Improves Outcomes in Opioid Dependence
Improvement seen in treatment satisfaction and several secondary end points for depot buprenorphine vs sublingual buprenorphine
Improvement seen in treatment satisfaction and several secondary end points for depot buprenorphine vs sublingual buprenorphine
To learn more about the overlapping crises of the opioid epidemic and the COVID-19 pandemic, Psychiatry Advisor interviewed pain specialist Paul J. Christo, MD, MBA, the Director of the Multidisciplinary Pain Fellowship Program at Johns Hopkins Hospital in Baltimore, Maryland.